We price generic and off-patent medicines to maintain their quality, safety and reliability.
When a Pfizer medicine becomes generic, we continue to monitor the quality, safety and reliability of the medicine. We also continue to invest in manufacturing, which can be very complex for certain types of medicines.
We also consider how many other companies supply the medicine.
Marketplace changes, such as the number of suppliers for a particular medicine or biologic, can also impact how we price such medicines.